Board Members | Syncom Formulations (India) Ltd. | R Wadiwala Securities Pvt Ltd

SYNCOM FORMULATIONS (INDIA) LTD.

NSE : SYNCOMFBSE : 524470ISIN CODE : INE312C01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE14.92-0.02 (-0.13 %)
PREV CLOSE (Rs.) 14.94
OPEN PRICE (Rs.) 14.77
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 168792
TODAY'S LOW / HIGH (Rs.)14.77 15.03
52 WK LOW / HIGH (Rs.)14.1 23.46
NSE14.92-0.03 (-0.2 %)
PREV CLOSE( Rs. ) 14.95
OPEN PRICE (Rs.) 14.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 14.92 (27)
VOLUME 1071384
TODAY'S LOW / HIGH(Rs.) 14.79 15.04
52 WK LOW / HIGH (Rs.)14.1 23.49

Company Information

ChairmanAnkit Kedarmal Bankda
Managing DirectorVijay Shankarlal Bankda
Company SecretaryVaishali Agrawal
Non Executive Independent DirectorRuchi Jindal
Ritesh Kumar Lunkad
Ankit Jain
Whole Time DirectorKedarmal Bankda
Incorporation Year : 21-06 1988
Registered Office :
7 Niraj Industrial Estate,Off Mahakali Caves Road,Andheri (E) Mumbai,
Maharashtra-400093 .
Phone :
022 30887744 / 54  
E-mail :
sfil87@syncomformulations.com
URL
www.sfil.in
Industry :
Pharmaceuticals & Drugs  
Listing :
BSE,NSE